Investing Profile

Beth Seidenberg

VCInvestor

General Partner at Kleiner Perkins

kleinerperkins.com/people/bet...San Francisco, California
Photo of Beth Seidenberg, General Partner at Kleiner Perkins

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Kleiner Perkins General Partner
$2.0M - $50.0M
$25.0M
54
750M
CompanyStageDateRound SizeTotal Raised
ACELYRIN
Series CSep 2022$300M
Series BNov 2021$250M
Series ADec 2020$8M
$560M
Co-investors: Richard Gaster (venBio), Dan Becker (Access Biotechnology)
ArsenalBio
Series BSep 2022$220M
Series AOct 2019$85M
$310M
Neuron23
Series CMar 2022$100M
Series BDec 2020$80M
Series ADec 2020$34M
$210M
Electra Therapeutics
Series BFeb 2022$84M
$84M
Co-investors: Carl Gordon (OrbiMed)
Kyverna Therapeutics
Series BJan 2022$85M
Series AJan 2020$25M
$110M
Expansion Therapeutics
Series BSep 2021$80M
Series AJan 2018$55M
$140M
Co-investors: Scott Rocklage (5am Ventures), Andrew Levin (RA Capital)
Capsida
Series AApr 2021$50M
$50M
Co-investors: Clare Ozawa (Versant Ventures)
Sagimet Biosciences
Venture RoundFeb 2021$80M
Series EAug 2019$7M
Series DDec 2014$29M
Series CJun 2013$20M
Venture RoundOct 2012$8.1M
Venture RoundJan 2012$20M
Series BJul 2009$30M
$190M
Co-investors: Robert Garland (New Enterprise Associates (NEA)), Matthew McAviney (New Enterprise Associates (NEA)), David Mott (Mott Family Capital)